| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.0M | — | — |
| R&D Expense | $2.2M | -52.8% | -72.9% |
| SG&A Expense | $5.3M | +108.4% | +73.4% |
| Operating Income | -$7.6M | -3.6% | +33.4% |
| Interest Expense | $100K | — | +0.0% |
| Pre-tax Income | -$7.2M | +16.2% | +41.3% |
| Income Tax | $6K | -91.7% | -93.8% |
| Net Income | -$7.2M | +16.8% | +41.7% |
| EPS (Basic) | -$0.27 | +15.6% | +41.3% |
| EPS (Diluted) | -$0.27 | +15.6% | +41.3% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $49.7M | +88.3% | — |
| Short-term Investments | $41.6M | +39.5% | — |
| Current Assets | $51.9M | -14.2% | — |
| Total Assets | $51.9M | -14.3% | — |
| Current Liabilities | $4.2M | -24.6% | — |
| Total Liabilities | $39.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$30.3M | — | — |
| Capital Expenditures | $23K | — | — |
| Investing Cash Flow | $40.4M | — | — |
| Financing Cash Flow | $25K | — | — |
| Free Cash Flow | -$30.3M | — | — |
| -3.4% |
| — |
| Stockholders' Equity | $12.7M | -36.4% | -61.6% |